Opioid Induced Constipation (OIC) Treatment Market Segmentation By Administration (Subcutaneous Injection, Rectal and Oral); By Drug Classes (Peripherally-Restricted μ-opioid Receptor Antagonist (PAMORA), Non-selective opioid antagonist, μ-Opioid antagonist and Locally Acting Chloride Channel Activator (LACCA)); By Distribution Channel (Hospital Pharmacies, Independent Pharmacies and Others) - Global Demand Analysis & Opportunity Outlook 2027
Choose the license type that fits your business needs
Individual Price
US $4550
- Report Accessible Right to 1 User Only
- No Printing/Editing Rights
- 8 Hours of Post-sale Assistance by Market Analyst
- 5% or 16 Hours Customization
Frequently purchased
Corporate Price
US $5050
- Report Accessible Rights to 5 Users
- Rights to Print/Edit
- 16 Hours of Post-Sales Assistance by Market Analyst
- 10% or 40 Hours Customization
- Direct Access to Lead Analyst
- Dedicated Account Manager
- 15% Discount on Next Report Purchase
Enterprise Price
US $8450
- Report Accessible Rights to Unlimited Users
- Rights to Print/Edit
- 40 Hours of Post-Sales Assistance by Market Analyst
- 20% or 70 Hours Customization
- Direct Access to Lead Analyst
- Dedicated Account Manager
- 15% Discount on Next Report Purchase
- Free Report Overview on Next Update within 1 Year
- 1 year On-Demand Exclusive Preview Rights for Recent Developments in the Industry
